Published in Am J Med on June 01, 1978
Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev (2007) 6.41
Immunoregulatory responses in experimental disseminated histoplasmosis: depression of T-cell-dependent and T-effectory responses by activation of splenic suppressor cells. Infect Immun (1979) 1.45
Immunoregulatory responses in experimental disseminated histoplasmosis: lymphoid organ histopathology and serological studies. Infect Immun (1979) 1.36
Differential diagnoses of bone marrow granuloma. West J Med (1996) 1.20
Vbeta4(+) T cells promote clearance of infection in murine pulmonary histoplasmosis. J Clin Invest (1998) 1.06
Identification of constituents of human neutrophil azurophil granules that mediate fungistasis against Histoplasma capsulatum. Infect Immun (2000) 1.02
Disseminated histoplasmosis as pseudo Richter's transformation in a patient with chronic lymphocytic leukemia. Am J Hematol (2015) 1.00
The URA5 gene is necessary for histoplasma capsulatum growth during infection of mouse and human cells. Infect Immun (1999) 0.98
Sarcoidosis possibly predisposing to disseminated histoplasmosis. Thorax (1988) 0.95
Immunosuppression related to collagen-vascular disease or its treatment. Proc Am Thorac Soc (2005) 0.95
Pulmonary Histoplasmosis. Curr Infect Dis Rep (2001) 0.87
Caecal perforation in a renal transplant patient with disseminated histoplasmosis. J Clin Pathol (1988) 0.85
Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation. Clin Microbiol Rev (1997) 0.85
Septic arthritis due to Histoplasma capsulatum in a leukaemic patient. Ann Rheum Dis (1985) 0.81
Pneumonia due to Histoplasma capsulatum in a bone marrow transplant recipient. Thorax (1987) 0.81
Progressive disseminated histoplasmosis in systemic lupus erythematosus-an unusual presentation of acute tenosynovitis and a literature review. Clin Rheumatol (2012) 0.81
Colonic histoplasmosis. Gastroenterol Hepatol (N Y) (2007) 0.80
Modulation of the effector function of human macrophages for Histoplasma capsulatum by HIV-1. Role of the envelope glycoprotein gp120. J Clin Invest (1997) 0.79
History of medical mycology in the united states. Clin Microbiol Rev (1996) 0.78
Histoplasma capsulatum, lung infection and immunity. Future Microbiol (2015) 0.77
Zinc Induces Dendritic Cell Tolerogenic Phenotype and Skews Regulatory T Cell-Th17 Balance. J Immunol (2016) 0.75
A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N Engl J Med (2005) 17.06
A comparison of the choline-esterase activities of the blood-sera from various species. Biochem J (1933) 15.78
Proposed diagnostic criteria for neurocysticercosis. Neurology (2001) 9.15
Extended use of nursing services in general practice. Br Med J (1967) 6.35
Nosocomial infection by gentamicin-resistant Streptococcus faecalis. An epidemiologic study. Ann Intern Med (1987) 5.74
Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science (1997) 5.54
The practice nurse--a new look. Br Med J (1970) 5.16
Studies on the epidemiology of adverse drug reactions. V. Clinical factors influencing susceptibility. Ann Intern Med (1966) 5.11
Ligand binding to integrins. J Biol Chem (2000) 4.94
Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med (1993) 4.72
Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis (2001) 4.01
Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) (1990) 3.95
Group C streptococcal bacteremia: analysis of 88 cases. Rev Infect Dis (1991) 3.88
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
Aetiology and management of bronchiolitis and pneumonia in childhood. Br Med J (1965) 3.76
Diagnosis of chlamydial infection in women attending antenatal and gynecologic clinics. J Clin Microbiol (1987) 3.70
The oxygen consumption of the frog's heart: I. J Physiol (1928) 3.63
ABT-378/ritonavir plus stavudine and lamivudine for the treatment of antiretroviral-naive adults with HIV-1 infection: 48-week results. AIDS (2001) 3.35
n of 1 trials comparing a non-steroidal anti-inflammatory drug with paracetamol in osteoarthritis. BMJ (1994) 3.34
A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells. Cell (1989) 3.34
Reactions to tetanus toxoid. J Hyg (Lond) (1973) 3.33
Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med (1994) 3.32
The Estimation of Fat in Blood. Biochem J (1925) 3.12
Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci U S A (2001) 3.07
Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med (1991) 3.03
Human lymphocytic metabolism. Effects of cyclic and noncyclic nucleotides on stimulation by phytohemagglutinin. J Clin Invest (1971) 3.01
International Conference for the Development of a Consensus on the Management and Prevention of Severe Candidal Infections. Clin Infect Dis (1997) 2.78
Local immune response in experimental pyelonephritis. J Clin Invest (1969) 2.73
DNA amplification and reverse dot blot hybridization for detection and identification of mycobacteria to the species level in the clinical laboratory. J Clin Microbiol (1992) 2.71
Localization of urinary-tract infections by detection of antibody-coated bacteria in urine sediment. N Engl J Med (1974) 2.63
Cultivation of Pneumocystis carinii with WI-38 cells. J Clin Microbiol (1979) 2.63
Eikenella corrodens, a recently recognized pathogen: infections in medical-surgical patients and in association with methylphenidate abuse. Medicine (Baltimore) (1974) 2.61
Cyclic adenosine 3',5'-monophosphate in human lymphocytes. Alterations after phytohemagglutinin stimulation. J Clin Invest (1971) 2.61
NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis. Am J Med (1994) 2.60
Use of a colorimetric system for yeast susceptibility testing. J Clin Microbiol (1995) 2.54
Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med (1979) 2.51
Human deficiency of the eighth component of complement. The requirement of C8 for serum Neisseria gonorrhoeae bactericidal activity. J Clin Invest (1976) 2.45
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents. J Clin Invest (1973) 2.42
Treatment of neurocysticercosis: current status and future research needs. Neurology (2006) 2.41
Comparison of PCR detection of mecA with standard susceptibility testing methods to determine methicillin resistance in coagulase-negative staphylococci. J Clin Microbiol (1996) 2.37
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis. Clin Infect Dis (2001) 2.25
RED: a red-cell antibody identification expert module. J Med Syst (1985) 2.24
Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis. J Infect Dis (1990) 2.22
General practitioners in hospital. Br Med J (1970) 2.22
New rat model of Pneumocystis carinii infection. J Clin Microbiol (1988) 2.21
Effects of storage temperature and pH on the stability of eleven beta-lactam antibiotics in MIC trays. J Clin Microbiol (1985) 2.21
Excess mortality associated with influenza in England and Wales. Int J Epidemiol (1977) 2.20
Current therapy for cutaneous melanoma. J Am Acad Dermatol (1995) 2.19
Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. J Clin Microbiol (1994) 2.17
Frequency of immediate adverse effects associated with therapeutic apheresis. Transfusion (1999) 2.17
Lung hypoplasia and neonatal death in Fgf9-null mice identify this gene as an essential regulator of lung mesenchyme. Development (2001) 2.16
MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res (2001) 2.12
Excess deaths attributable to influenza in England and Wales: age at death and certified cause. Int J Epidemiol (1983) 2.12
Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. J Clin Microbiol (1998) 2.11
Comparison of virulence markers of peritoneal and fallopian tube isolates with endocervical Neisseria gonorrhoeae isolates from women with acute salpingitis. Infect Immun (1980) 2.11
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group. N Engl J Med (1996) 2.10
Expression of mef2 genes in the mouse central nervous system suggests a role in neuronal maturation. J Neurosci (1995) 2.10
Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord (2000) 2.10
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis (2007) 2.09
Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature. Clin Infect Dis (1996) 2.09
Nucleotide sequence variation in Pneumocystis carinii strains that infect humans. J Clin Microbiol (1993) 2.08
Practice guidelines for the management of patients with blastomycosis. Infectious Diseases Society of America. Clin Infect Dis (2000) 2.08
Bacterial infection-associated improvement of platelet counts in two patients with chronic and unresponsive idiopathic thrombocytopenic purpura with normal platelet survival studies. Br J Haematol (1995) 2.07
The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin. J Cell Biol (1990) 2.07
Alopecia associated with fluconazole therapy. Ann Intern Med (1995) 2.05
Neurocysticercosis in Houston, Texas. A report of 112 cases. Medicine (Baltimore) (1994) 2.05
Duration of immunity after active immunisation against tetanus. Lancet (1969) 2.04
Itraconazole therapy for blastomycosis and histoplasmosis. NIAID Mycoses Study Group. Am J Med (1992) 2.01
Progressive disseminated histoplasmosis. A prospective study of 26 patients. Ann Intern Med (1972) 1.99
Radioimmunoassay for prostaglandins. Science (1971) 1.99
Primary sarcomas of the mediastinum: results of therapy. J Thorac Cardiovasc Surg (1998) 1.96
Immune interactions with cells infected with herpes simplex virus: antibodies to radioiodinated surface antigens. J Immunol (1977) 1.94
The influence of a competitor on the geographic mosaic of coevolution between crossbills and lodgepole pine. Evolution (2001) 1.93
Bactericidal and opsonic activity against Neisseria gonorrhoeae in sera from patients with disseminated gonococcal infection. J Infect Dis (1976) 1.91
Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol (1990) 1.90
Single-concentration broth microdilution test for detection of high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1987) 1.85
Identification of chromosomal location of mupA gene, encoding low-level mupirocin resistance in staphylococcal isolates. Antimicrob Agents Chemother (1996) 1.83
Candiduria: a randomized, double-blind study of treatment with fluconazole and placebo. The National Institute of Allergy and Infectious Diseases (NIAID) Mycoses Study Group. Clin Infect Dis (2000) 1.80
Methicillin-resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. The AHA Technical Panel on Infections Within Hospitals. Infect Control Hosp Epidemiol (1994) 1.79
Antimicrobial susceptibility of Pneumocystis carinii in culture. Diagn Microbiol Infect Dis (1985) 1.78
FTDP-17: an early-onset phenotype with parkinsonism and epileptic seizures caused by a novel mutation. Ann Neurol (1999) 1.75
Laparoscopic transperitoneal procedure for routine repair of groin hernia. Br J Surg (2002) 1.75
THE CATEGORY OF TOPOLOGICAL OBJECTS. Proc Natl Acad Sci U S A (1961) 1.73
Alcohol and other substance abuse and impairment among physicians in residency training. Ann Intern Med (1992) 1.72
Activity of lipid-soluble inhibitors of dihydrofolate reductase against Pneumocystis carinii in culture and in a rat model of infection. Antimicrob Agents Chemother (1987) 1.72
Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample? Am J Obstet Gynecol (1980) 1.71
Prevention of tetanus in the wounded. Br Med J (1975) 1.71
HIV transmitted by sexual intercourse but not by kissing. Br Med J (Clin Res Ed) (1987) 1.70
Observations on the collagen and proteinpolysaccharide complex of rabbit cornea stroma. J Cell Sci (1969) 1.70
Repeated gonorrhea: an analysis of importance and risk factors. J Infect Dis (1978) 1.70
Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med (1983) 1.70
Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol (1988) 1.69
Imported malaria in pregnancy: report of four cases and review of management. Clin Infect Dis (1992) 1.68
Use of the 51 Cr release test to demonstrate patterns of antibody response in humans to herpesvirus types 1 and 2. J Immunol (1972) 1.68
Comparative study of district and community hospitals. Br Med J (1973) 1.67
Characterization of pneumococcal specific antibodies in healthy unvaccinated adults. Vaccine (1998) 1.66
The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: a specific marker of multiple system atrophy? Arch Neurol (1999) 1.66